Your browser doesn't support javascript.
loading
BCR-ABL1 transcript decline ratio combined BCR-ABL1IS as a precise predictor for imatinib response and outcome in the patients with chronic myeloid leukemia.
Cai, Zhimei; Jia, Xiting; Zi, Jie; Song, Huihui; Wang, Shujun; McGrath, Mary; Zhao, Lidong; Song, Chunhua; Ge, Zheng.
Afiliación
  • Cai Z; Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
  • Jia X; Department of Hematology, The First People's Hospital of Lianyungang, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, China.
  • Zi J; Department of Hematology, The First People's Hospital of Lianyungang, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, China.
  • Song H; Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
  • Wang S; Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
  • McGrath M; Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
  • Zhao L; Hershey Medical Center, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA.
  • Song C; Department of Hematology, The First People's Hospital of Lianyungang, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, China.
  • Ge Z; Hershey Medical Center, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA.
J Cancer ; 11(8): 2234-2240, 2020.
Article en En | MEDLINE | ID: mdl-32127950
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cancer Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cancer Año: 2020 Tipo del documento: Article País de afiliación: China